Irish Pharmaceutical Healthcare Association

Lobbying Organisation Irish Pharmaceutical Healthcare Association

Date published 19 Jan, 2016

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 Sep, 2015 to 31 Dec, 2015

Specific Details European Commission Country Specific Recommendations (CSRs) on Ireland related to expenditure on prescription medicines

Intended results To bring to the European Commission IPHA concerns about the CSRs related to expenditure on prescription medicines

Name of person primarily responsible for lobbying on this activity Oliver O'Connor (CEO)

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) Yes

Current or Former Designated Public Official(s)

Oliver O'Connor (Former DPO) Special Adviser (Department of Health)

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Email (2-5)

Emails regarding meeting with Brian Hayes MEP and arrangements with his office to set up meeting with the European Commission to discuss the CSRs for Ireland

Meeting (1)

Meeting with Brian Hayes MEP at which IPHA concerns on European Commission CSRs for Ireland were discussed

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Brian Hayes MEP (European Parliament)